AI assistant
CONMED Corp — Director's Dealing 2019
May 29, 2019
31971_dirs_2019-05-29_c89951d4-3371-49a3-b75a-ded36ee49b21.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-05-28
Reporting Person: Berge Terence M (VP-Corporate Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-28 | Common Stock | S | 3218 | $82.83 | Disposed | 23851 | Direct |
| 2019-05-28 | Common Stock | S | 3943 | $83.19 | Disposed | 19908 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.45 to $82.995. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.01 to $83.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.